Skip to main content

Peer Review reports

From: Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

Original Submission
20 Mar 2009 Submitted Original manuscript
23 Apr 2009 Reviewed Reviewer Report - Raymund Roos
21 May 2009 Reviewed Reviewer Report - Ralf Reilmann
14 Jul 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 2
14 Jul 2009 Submitted Manuscript version 2
11 Sep 2009 Reviewed Reviewer Report - Raymund Roos
17 Nov 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 3
17 Nov 2009 Submitted Manuscript version 3
1 Dec 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 4
1 Dec 2009 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
10 Dec 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 6
10 Dec 2009 Submitted Manuscript version 6
Publishing
18 Dec 2009 Editorially accepted
18 Dec 2009 Article published 10.1186/1471-2377-9-62

You can find further information about peer review here.

Back to article page